JW Asset Management »

Catalyst Pharmaceutical Partners shares owned by JW Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by JW Asset Management from 13F filings

Historical chart of JW Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by JW Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by JW Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 413k 16.81
2023-09-30 $6.6M 563k 11.69
2023-06-30 $7.6M 563k 13.44
2023-03-31 $9.3M 563k 16.58
2022-12-31 $11M 563k 18.60

More positions owned by JW Asset Management

Establishment Labs Holdings Ord (ESTA)
Celsius Hldgs Com New (CELH)
Eli Lilly & Co. (LLY)
Novo-nordisk A S Adr (NVO)
NVIDIA Corporation (NVDA)
Vita Coco Co Inc/the (COCO)
Catalyst Pharmaceutical Partners (CPRX)
Advisorshares Tr Pure Us Cannabis (MSOS)
Heron Therapeutics (HRTX)
Abercrombie & Fitch Cl A (ANF)
Snap Cl A (SNAP)
Idaho Strategic Resources Com New (IDR)
Eaton Corp SHS (ETN)
Caterpillar (CAT)
Faze Holdings Common Stock

View all positions for JW Asset Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners